Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

The Digital Divide in Cancer Care: The Main Problem Is Access, Not Use

The Digital Divide in Cancer Care: The Main Problem Is Access, Not Use
In this article
JCO ONCOLOGY PRACTICE • NOVEMBER 19, 2025

The First-Step Crisis in Cancer Patients' Digital Journey

How do the most vulnerable patients use digital health systems? Is the barrier using them, or getting through the door?

A quiet but profound shift is occurring in oncology: treatment is moving from hospital infusion units to patients' homes, and from intravenous therapy to oral targeted drugs . Although this home-treatment era offers comfort and freedom, it creates a new blind spot for clinicians.

Oral anticancer medicines require strong adherence and close symptom monitoring. Are patients taking them? Can they contact their doctor promptly when side effects begin? At this point, patient portals (digital health records) become a safety necessity rather than a luxury. But is technology equally accessible to every patient?

On November 19, 2025, the American Society of Clinical Oncology's respected publication JCO Oncology Practicepublished research led by Dr. Yenong Cao addressing precisely this problem. It shows how vulnerable patients risk exclusion from this digital component of modern cancer care.

Study Design and Methodology

This retrospective analysis at Tufts Medical Center in Boston examined digital behavior among patients starting oral anticancer treatment. Its details were:

  • Sample: Among patients starting oral cancer treatment between October 2022 and March 2024, 280 patients were examined.
  • Analysis Criteria: Researchers assessed "active use"—sending at least one message—and "meaningful use"—two-way patient–provider messaging.
  • Proxy Analysis: English messages sent by patients who did not speak English, or message content, helped determine whether the patient or a family member used the portal.

Criteria for "Vulnerable" Patients

56% of the population met at least one of these criteria:

👴🏻
Age 75 and Older
(20%)
🗣️
Non-English Speakers
(Language Barrier 26%)
🏥
Low-Income Insurance
(Medicaid 30%)

1. The Problem: Registering for the System (Getting Through the Door)

Vulnerable patients had substantially lower initial registration rates. Statistical analyses showed that, rather than age or insurance, the language barrier was the biggest obstacle.

Nonvulnerable Patients
87% Registered
Vulnerable Patients
64% Registered
🚨 Statistical Significance: Patients who did not speak English were dramatically less likely to register (Odds Ratio: 0.27; p < .0001).

A Surprising and Encouraging Finding

The key point: once vulnerable patients registered and overcame the barrier, their portal use and meaningful interactions were similar to other patients'. 31% of registered patients used the portal specifically to discuss oral medications.

Hidden Heroes: "Proxy" Users (Family/Companions)

Older patients and those with language barriers rely heavily on family members as proxies to use technology. This demonstrates that gaps in digital literacy can be overcome through social support .

👤
2.8%
In Nonvulnerable Patients
Use through another person
👥
17%
In Vulnerable Patients
Use through another person

👨‍⚕️ DROZDOGAN Academy Commentary:

From a health informatics perspective, this study shows that designing technology is not enough: we must also provide "digital navigation" support to help patients take the first step.

Especially for patients over 75 or facing language barriers, integrating not only the patient but also family members (children, grandchildren) into the system is key to improving adherence. When digital tools are accessible, even the most vulnerable patients can use them competently.


Source: Cao Y, Bate Baiyee MN, Ching J, et al. Epic Patient Portal Adoption Among Vulnerable Oncology Patients in the Era of Oral Anticancer Medications. JCO Oncol Pract. Published online November 19, 2025. doi:10.1200/OP-25-00630 Article Link

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

The Digital Divide in Cancer Care: The Main Problem Is Access, Not Use

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy